CBD Oral Solution (eCBD system Target)
2020-3424
Phase 2 small_molecule active
Quick answer
CBD Oral Solution (eCBD system Target) for Fragile X Syndrome is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Fragile X Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active